FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...
A woman who watched her own mother live with the debilitating effects of multiple sclerosis (MS) for over 20 years and has ...
In this installment in our series about diseases preventable by vaccination, we examine hepatitis A and why protection from ...
The new WHO guidance strengthens the fight against Plasmodium vivax malaria by combining safer radical cure medicines with routine G6PD testing to prevent dangerous side effects. By clearing both ...
Irritable bowel syndrome (IBS) symptoms can come and go over time. When they are present, the symptoms can last anywhere from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results